NOTABLE PUBLICATIONS

ACG Clinical Guideline: Ulcerative Colitis in Adults.
Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. Am J Gastroenterol. 2019;114:384-413.

The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.
Swaminath A, Berlin EP, Cheifetz, Hoffenberg E, Kinnucan J, Wingate L, Buchanan S, Zmeter N, Rubin DT. Inflamm Bowel Dis. 2019. 25:427-35

Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
Christensen B, Hanauer SB, Erlich J, Kassim O, Gibson PR, Turner JR, Hart J, Rubin DT. Clin Gastroenterol Hepatol. 2017. 15:1557-64

The Crohn’s and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Healthcare Access. 
Rubin DT, Feld LD, Goeppinger S, Kim S, Margolese JM, Rosh J, Rubin M, Rodriquez DM, Wingate L. Inflamm Bowel Dis. 2017. 23:224-32

Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel Disease.
Rubin DT, Krugliak Cleveland N. Am J Gastroenterol. 2015. 110:1252-6

Inflammation is an Independent Risk Factor for Colonic Neoplasia in Patients with Ulcerative Colitis: A Case-Control Study.
Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR. Clin Gastroenterol Hepatol. 2013. 11:1601-8

Ethical Consideration for Clinical Trials in Inflammatory Bowel Disease. 
Rubin DT, Becker S, Siegler M. Gastroenterol Hepatol. 2014;10:37-41